Australia's most trusted
source of pharma news
Tuesday, 19 March 2024
After a rough year in the wake of plummeting demand for its products, this CEO's pay was slashed by an eye-watering AU$17.3 million in 2023, but he's still quite a way from the breadline, taking home AU$32.8 million.